Nice to read your account Bassman.
Yeah a few good points here. Once we eventually pass thru P3 and we are commercialised, there will be no question of manufacturing prowess, consistency of material and pure and excellent workmanship. The batch to batch consistency is unquestionable. Bene have been manufacturing and refining this PPS product for more than 70 years. I do wonder about the compounding side. It's probably at least an option for the few that can try it and are in pain and are across what it can do for you etc. But maybe you have a point of the variability in a compounded state and whatever else they need to prepare the final product at a Compounding Pharmacy level??
Yes you are right, each person will have some variability. I really look forward to some of the amazing patient stories to come in the future and how it positively affects many lives.
All the best for your impending surgery.
Also, you prob know this but iPPS can help in post op pain relief too.
Cheers
Mozz
- Forums
- ASX - By Stock
- compounding chemist
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
31.0¢

Nice to read your account Bassman.Yeah a few good points here....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.7M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 29.0¢ | $151.6K | 495.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 30530 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 2182 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30530 | 0.290 |
4 | 81205 | 0.285 |
18 | 351187 | 0.280 |
6 | 64032 | 0.275 |
5 | 95941 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 2182 | 1 |
0.315 | 70433 | 5 |
0.320 | 108906 | 8 |
0.325 | 171282 | 7 |
0.335 | 25000 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online